SAVE THE DATE: BOPA Introduction to Cancer Course 2025

The popular Introduction to Cancer Course returns to Leeds in May 2025, with a renewed agenda.

The BOPA Introduction to Course Course 2025
  • WHEN: Thursday 1st & Friday 2nd May 2025
  • WHERE: The Bridge Conference Centre, Rider Street, Leeds LS9 7BQ (1.3 miles (10 min Taxi or 20min walk) from Leeds Train Station)
  • COST: £50 per day (travel and accommodation not included)
  • CONTENT: Click to see Agenda

Registration opens Thursday 6th March 9am

Due to budget pressure, it is likely that only one Introduction to Cancer course will be held in 2025. Moreover, we have taken the difficult decision to charge delegates a contribution towards the running of the course in order to ensure the financial sustainability of BOPA and the long-term future of the BOPA ITC.

 

Rest assured the content and quality of the Introduction to Cancer course will remain of the greatest value with high quality speakers.

We have introduced a new agenda for 2025 which incorporates additional sessions on Paediatric Oncology, Haematology and Genomics, as well as traditional sessions on Oncological Emergencies, Verification and Side Effects of SACT which have received great feedback in the past.

 

Please ensure study leave is confirmed prior to registration.

Visit the BOPA Introduction to Course page for more information for the course. Don’t forget to follow #BOPAITC on social media for all the updates!

 

Latest News

By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article
By BOPA Committee on 27th April 2025

Women for Oncology UK Spring Webinar

The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…

Read article
By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article